Bioequity Europe 2015
Erytech Pharma attends Bioequity Europe 2015 on May 19 and 20, 2015 in Vienna, Austria and makes a presentation on May 19 at 5 pm. The post Bioequity Europe 2015 appeared first on Erytech Pharma.
View ArticleERYTECH announces oral presentations of GRASPA® Phase III results at ASCO and...
ERYTECH announces oral presentations of GRASPA® Phase III results at ASCO and EHA annual meetings The post ERYTECH announces oral presentations of GRASPA® Phase III results at ASCO and EHA annual...
View ArticleBoston CEO Conference
ERYTECH Pharma participates in Boston CEO Conference on May 26 and 27, 2015 in Boston, MA, USA The post Boston CEO Conference appeared first on Erytech Pharma.
View Article51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
ERYTECH participe au 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) which takes place in Chicago, Il, USA from May 29 to June 2, 2015 and makes a poster and an oral...
View ArticleJefferies 2015 Healthcare Conference
ERYTECH PHARMA attends Jefferies 2015 Healthcare Conference from June 1 to 4, 2015 in New-York, NY, USA The post Jefferies 2015 Healthcare Conference appeared first on Erytech Pharma.
View ArticleERYTECH reported full GRASPA® Phase III results in ALL and provided update on...
ERYTECH Pharma reported complete Phase III results of its pivotal program with GRASPA® in Acute Lymphoblastic Leukemia (ALL) and presented the design of the ongoing Phase IIb study in Acute Myeloid...
View ArticleERYTECH : ANNUAL GENERAL MEETING OF JUNE 23, 2015
ERYTECH today announced the modalities for making available documents for the Annual General Meeting of June 23, 2015. The post ERYTECH : ANNUAL GENERAL MEETING OF JUNE 23, 2015 appeared first on...
View ArticleERYTECH announces presentation and webcast at the Jefferies 2015 Healthcare...
ERYTECH Pharma announces that Gil Beyen, Chairman & CEO of the company, will present a company overview at the Jefferies 2015 HealthCare Conference in New York on June 4 at 9:00 am Eastern Time....
View ArticleEHA 20th Congress
ERYTECH Pharma participates and presents at EHA 20th Congress which takes place from June 11 to 14, 2015 in Vienna, Austria. The post EHA 20th Congress appeared first on Erytech Pharma.
View ArticleBIO 2015 Philadelphia
ERYTECH Pharma attends BIO 2015 in Philadelphia, PA, USA from June 15 to 18, 2015. The post BIO 2015 Philadelphia appeared first on Erytech Pharma.
View ArticleChargé(e) de Recherche
MISSIONS Sous la supervision du directeur de pôle « développement produit », vous aurez pour principales missions : de participer au développement de nouveaux produits pour la réalisation des études...
View ArticleERYTECH announces two positive DSMB reviews
ERYTECH Pharma announces positive safety reviews after the completion of the first cohort in the company’s US Phase I study with ERY-ASP in Acute Lymphoblastic Leukemia (ALL), and following the...
View ArticleTECHNICIEN(NE) DE LABORATOIRE DE RECHERCHE
ERYTECH Pharma recherche pour son Département Recherche et Développement un(e) : TECHNICIEN(NE) DE LABORATOIRE DE RECHERCHE Rattaché(e) au pôle « Développement Produit » du service préclinique /...
View ArticleERYTECH reports financial highlights for Q2 2015
ERYTECH Pharma reports cash balance and revenues for the second quarter of 2015 The post ERYTECH reports financial highlights for Q2 2015 appeared first on Erytech Pharma.
View ArticleERYTECH appoints Dr. Iman El-Hariry as Chief Medical Officer
ERYTECH Inc., the US affiliate of ERYTECH Pharma announces the appointment of Iman El-Hariry as Chief Medical Officer, responsible for global medical, clinical and regulatory affairs The post ERYTECH...
View ArticleERYTECH announces positive safety review for ERY-ASP in its Phase 2 study in...
ERYTECH Pharma announces a positive DSMB safety review following the treatment of the first twenty-four patients with ERY-ASP in its Phase 2 study in pancreatic cancer The post ERYTECH announces...
View ArticleERYTECH announces plans to conduct registered initial public offering in the...
ERYTECH Pharma today announced that the Company plans to conduct a registered initial public offering in the United States The post ERYTECH announces plans to conduct registered initial public offering...
View ArticleERYTECH to host a webcast on September 29, 2015 for its 2015 half-year results
WEBCAST - ERYTECH Pharma will announce its half-year results for 2015 on Monday September 28, 2015, after market close, and hold a presentation webcast on the September 29, 2015 at 2:30 pm CET / 8:30...
View ArticleERYTECH strengthens its intellectual property position with the issuance of...
ERYTECH Pharma announces the issuance of a new patent in the United States The post ERYTECH strengthens its intellectual property position with the issuance of United States patent for erythrocytes...
View ArticleERYTECH provides business update and financial results for the first half of...
ERYTECH Pharma provides a business update and reports its financial results for the six-month period ending June 30, 2015 The post ERYTECH provides business update and financial results for the first...
View Article